+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Outcomes of stage 3-5 chronic kidney disease before end-stage renal disease at a single center in Taiwan



Outcomes of stage 3-5 chronic kidney disease before end-stage renal disease at a single center in Taiwan



Nephron. Clinical Practice 109(3): C109-C118



Background: Taiwan has the highest incidence of end-stage renal disease ( ESRD) in the world, but little is known about the outcomes of patients with chronic kidney disease ( CKD) before ESRD in Taiwan. This study investigated the rate of renal progression and predictors for ESRD and death in a prospective cohort of patients under usual nephrologic care at a single center.Methods: A total of 433 patients at CKD stage 3-5 short of dialysis were recruited from nephrology clinics. Patients were monitored for up to 36 months or until ESRD, death or loss to follow-up. Glomerular filtration rates ( GFR) were calculated by the Modification of Diet in Renal Disease abbreviated formula.Results: At baseline, mean age was 65.6 years, 61.7% were male, 33.3% were diabetic and 29.1% had cardiovascular diseases (CVD). At the end of followup, 123 patients (28.4%) had advanced to ESRD and 41 (9.5%) had died. Mean annual declines in GFR were 2.24, 4.22, and 3.23 ml/min/1.73 m(2) for stages 3, 4, and 5, respectively. By Cox regression model, patients with CVD, lower BMI and higher systolic BP were more likely to develop ESRD. Older patients with CVD and lower systolic BP were more likely to die.Conclusion: In this CKD cohort, patients were more likely to develop ESRD than cardiovascular death. The rate of GFR decline and predictors of ESRD were comparable to those reported in Western countries. Thus, the high incidence of ESRD in Taiwan may be attributed, at least in part, to lower cardiovascular mortality. Copyright (c) 2008 S. Karger AG, Basel.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 032677268

Download citation: RISBibTeXText

PMID: 18663322

DOI: 10.1159/000145453


Related references

Chronic kidney disease progression to end stage renal disease: a single center experience of the role of the underlying kidney disease. Therapeutic Apheresis and Dialysis 17(4): 363-367, 2014

Is renal hyperfiltration protective in chronic kidney disease-stage 1 pregnancies? A step forward unravelling the mystery of the effect of stage 1 chronic kidney disease on pregnancy outcomes. Nephrology 20(3): 201-208, 2015

Results of Fabry Disease Screening in Male Pre-End Stage Renal Disease Patients with Unknown Etiology Found Through the Platform of a Chronic Kidney Disease Education Program in a Northern Taiwan Medical Center. Kidney and Blood Pressure Research 43(5): 1636-1645, 2018

Prognostic significance of pre-end-stage renal disease serum alkaline phosphatase for post-end-stage renal disease mortality in late-stage chronic kidney disease patients transitioning to dialysis. Nephrology, Dialysis, Transplantation 33(2): 264-273, 2017

Conservatively managed patients with stage 5 chronic kidney disease--outcomes from a single center experience. Qjm 102(8): 547-554, 2010

Outcomes of end-stage renal disease patients on the waiting list for deceased donor kidney transplantation: A single-center study. Kidney Research and Clinical Practice 2019, 2019

Transition of patients from chronic kidney disease to end-stage renal disease: better practices for better outcomes. Disease Management 9(6): 311-315, 2006

Outcomes of patients with end-stage renal disease (ESRD) under chronic hemodialysis requiring continuous renal replacement therapy (CRRT) and patients without ESRD in acute kidney injury requiring CRRT: a single-center study. Hemodialysis International. International Symposium on Home Hemodialysis 16(4): 456-464, 2013

Stroke risk and outcomes in patients with chronic kidney disease or end-stage renal disease: Two nationwide studies. Plos One 13(1): E0191155, 2018

End-stage renal disease after kidney donation: a single-center experience. Transplantation Proceedings 40(5): 1315-1318, 2008

Overcoming barriers to the early detection and treatment of chronic kidney disease and improving outcomes for end-stage renal disease. American Journal of Managed Care 8(4 Suppl): S122-35; Quiz S136-9, 2002

Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease. Clinical Nephrology 80(4): 256-262, 2013

Does stage III chronic kidney disease always progress to end-stage renal disease? A ten-year follow-up study. Yearbook of Medicine 2012: 169-171, 2012

Does stage III chronic kidney disease always progress to end-stage renal disease? A ten-year follow-up study. Scandinavian Journal of Urology and Nephrology 46(3): 232-238, 2012

Outcomes of renal transplantation after end-stage renal disease due to diabetic nephropathy: a single-center experience. Transplantation Proceedings 44(1): 77-79, 2012